Mapping COVID-19 Spread in a Tertiary Hospital
MEDyMAP
Evaluation of the Response of COVID-19 Spread With a Spatiotemporal Analysis in a Tertiary Hospital
1 other identifier
observational
2,646
1 country
2
Brief Summary
One of the major problems in suppressing the spreading of an epidemic resides in understanding and monitoring its propagation patterns, and in evaluating how these are modified by enforced policies. The standard solution requires detailed information at the microscopic scales, e.g. how infected people have moved and whom they came in contact with, which is hardly ever available. The researchers propose a novel approach to the study of the propagation of COVID-19, in which a proxy of this information is derived at macroscopic scales. This will be based on two ingredients: the spatiotemporal study in shiny with mathematical models with aggregated or non aggregated data and the reconstruction of functional networks of spreading patterns, and the development of a supporting software.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2020
CompletedFirst Submitted
Initial submission to the registry
October 7, 2020
CompletedFirst Posted
Study publicly available on registry
October 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2021
CompletedNovember 10, 2021
November 1, 2021
5 months
October 7, 2020
November 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
spatiotemporal spread
spatiotemporal spread of COVID-19 patient in our hospital
February 1, 2020 to September 30, 2020
Secondary Outcomes (1)
classification score
February 1, 2020 to September 30, 2020
Interventions
just descriptive analysis of clinical data
Eligibility Criteria
Patients with a positive test (PCR or serology) for SARS-CoV-2 in an outpatient regime system
You may qualify if:
- positive test (PCR or serology) for SARS-CoV-2
- outpatient follow-up
You may not qualify if:
- hospitalisation in ward or ICU
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital General Universitario de Valencialead
- University of Valenciacollaborator
Study Sites (2)
CHGUV
Valencia, 46014, Spain
CHGUV
Valencia, Spain
Related Publications (2)
Romero Garcia C, Iftimi A, Briz-Redon A, Zanin M, Otero M, Ballester M, de Andres J, Landoni G, de Las Marinas D, Catala Bauset JC, Mandingorra J, Conca J, Correcher J, Ferrer C, Lozano M. Trends in Incidence and Transmission Patterns of COVID-19 in Valencia, Spain. JAMA Netw Open. 2021 Jun 1;4(6):e2113818. doi: 10.1001/jamanetworkopen.2021.13818.
PMID: 34143191BACKGROUNDBriz-Redon A, Iftimi A, Correcher JF, De Andres J, Lozano M, Romero-Garcia C. A comparison of multiple neighborhood matrix specifications for spatio-temporal model fitting: a case study on COVID-19 data. Stoch Environ Res Risk Assess. 2022;36(1):271-282. doi: 10.1007/s00477-021-02077-y. Epub 2021 Aug 18.
PMID: 34421343BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesia and Critical care consultant
Study Record Dates
First Submitted
October 7, 2020
First Posted
October 9, 2020
Study Start
October 2, 2020
Primary Completion
February 15, 2021
Study Completion
June 15, 2021
Last Updated
November 10, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share
there is not ipd sharing planned